SCHEMBL23927100

SCHEMBL23927100

C=CC(N1C[C@@H]2C[C@H](O)CN(C(=O)O)[C@@H]2C1=O)C(C)(C)C

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.32
DPP8 Q6V1X1 2/20 0.32
DPP9 Q86TI2 2/20 0.32
RIPK1 Q13546 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19990696 0.71
SCHEMBL18797776 0.67 PIK3CD (0.41) DPP4DPP8DPP9RIPK1
SCHEMBL19990608 0.65 ATM (0.31)
SCHEMBL21981531 0.65 ATM (0.31)
SCHEMBL23927099 0.65 CYP1A2 (0.36) RIPK1
SCHEMBL19990787 0.64 RIPK1 (0.30) RIPK1
SCHEMBL19990731 0.61 ATM (0.34) DPP4DPP8DPP9
SCHEMBL19990704 0.61 ATM (0.34) DPP4DPP8DPP9
SCHEMBL28695065 0.59 NR1H2 (0.39) RIPK1
SCHEMBL746205 0.59 ATM (0.48) DPP4DPP8DPP9RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3698796-B1 PHARMACEUTICAL COMBINATION OF A TRICYCLIC BETA-LACTAMASE INHIBITOR WITH SPECIFIC BETA-LACTAM ANTIBIOTICS NOVARTIS AG (CH) 2021-10-27 EP disclosed